Results 21 to 30 of about 10,413 (156)

Cell cycle specific radiosensitisation by the disulfiram and copper complex [PDF]

open access: yes, 2017
The disulfiram and copper complex (DSF:Cu) has emerged as a potent radiosensitising anti-cancer agent. The ability of copper to stabilise DSF in a planar conformation and to inhibit DNA replication enzymes stimulated our investigation of the effect of
Anselmi, Giorgio   +3 more
core   +1 more source

Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells [PDF]

open access: yes, 2016
PURPOSE: Despite recent advances in the treatment of metastatic prostate cancer, survival rates are low and treatment options are limited to chemotherapy and hormonal therapy.
Mairs, Robert J., Rae, Colin
core   +2 more sources

Radiosensitization: Studies and Modern Approaches to Cellular Radiosensitivity

open access: yesInternational Journal of Biomedicine, 2023
Even though radiation therapy has achieved great success, there is still an unsolved task of increasing radiation damage to tumor tissue and reducing side effects on healthy tissues. There is a wide variety of obstacles that reduce the efficiency of radiotherapy.
openaire   +2 more sources

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Hydration and Radiosensitivity

open access: yesExperimental Biology and Medicine, 1955
Summary and Conclusions1. Artemia “eggs,” essentially in the blastula stage in suspended development, can tolerate about 200,- 000 r more x-radiation in the dry than in the wet state, if criteria of hatching and motility after 48 hours hydration are considered. 2.
R, RUGH, H, CLUGSTON
openaire   +2 more sources

Ultrasmall Platinum Nanoparticles for Radiation‐Enhanced Cancer Therapy

open access: yesAdvanced Functional Materials, EarlyView.
This work proposes a nanomedicine‐based strategy to enhance X‐ray radiotherapy for cancer treatment. Ultrasmall Pt‐NPs exhibit catalase‐like activity that may contribute to modulation of the tumor microenvironment and amplify interactions between radiation and biological matter, leading to increased DNA damage.
Miguel Encinas‐Gimenez   +8 more
wiley   +1 more source

Nanoparticle-Based Radiosensitization [PDF]

open access: yesInternational Journal of Molecular Sciences, 2020
Radiotherapy is a highly affordable treatment and provides many excellent outcomes [...]
openaire   +5 more sources

Plasmonic Nanomachines: Creating Local Potential Gradients and Motions

open access: yesAdvanced Materials, EarlyView.
Plasmonic nanomachines can generate optical, thermal, and chemical potential gradients to drive directional rectilinear, rotational, and twisting motions at the nanometer scale. The integration of multimodal plasmonic forces with functional materials and programmed structural distortions enables precise spatiotemporal actuation, thereby providing a ...
Yoonhee Kim   +3 more
wiley   +1 more source

BMN673 sensitizes rhabdomyosarcoma tumors to irradiation in vivo [PDF]

open access: yes, 2020
Bone and soft tissue sarcomas are mesenchymal tumors that occur rarely in adults, representing only 1% of total malignancies, but comprise up to 13% of malignant tumors in children.1 Rhabdomyosarcoma, a soft tissue sarcoma that commonly affects children,
Jacob, Connor
core  

EO9 (Apaziquone): from the clinic to the laboratory and back again [PDF]

open access: yes, 2013
EO9 (Apaziquone) is a bioreductive drug that has a chequered history. It underwent clinical trial but failed to show activity in phase II clinical trials when administered i.v.
Aamdal   +75 more
core   +1 more source

Home - About - Disclaimer - Privacy